The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Yakhno N.N.

Sechenov First Moscow State Medical University

Amelin A.V.

Pavlov First Saint Petersburg State Medical University

Akhmadeeva L.R.

Bashkir State Medical University

Barantsevich E.R.

Pavlov First Saint Petersburg State Medical University

Bykov Yu.N.

Federal State Budget Educational Institution of Higher Training Irkutsk State medical university of the Ministry of Health of the Russian Federation

Vorobeva O.V.

Chuvash state university named after I.N. Ulyanov

Volkova L.I.

Federal State Budget Educational Institution of Higher Education “Ural State Medical University” of the Ministry of Health of the Russian Federation

Davydov O.S.

Research Institute of General Pathology and Pathophysiology

Danilov A.B.

Sechenov First Moscow State Medical University (Sechenov University)

Devlikamova F.I.

Kazan State Medical Academy

Doronina O.V.

Federal State Budget Educational Institution of Higher Training Novosibirsk State medical university of the Ministry of Health of the Russian Federation

Iskra D.A.

Saint Petersburg State Pediatric Medical University

Kamchatnov P.R.

Federal State Autonomous Educational Institution of Higher Education «N.I. Pirogov Russian National Research Medical University» of the Ministry of Health of the Russian Federation

Karakulova Yu.V.

Wagner Perm State Medical University

Kukushkin M.L.

Research Institute of General Pathology and Pathophysiology

Kurushina O.V.

Volgograd State Medical University

Parfenov V.A.

Sechenov First Moscow State Medical University

Poverennova I.E.

Federal State Budgetary Educational Institution of Higher Education «Samara State Medical University» of the Ministry of Healthcare of the Russian Federation

Rachin A.P.

National Research Medical Center for Rehabilitation and Balneology

Churyukanov M.V.

Sechenov First Moscow State Medical University (Sechenov University);
Petrovsky National Research Centre of Surgery

Shirokov V.A.

Yekaterinburg Medical Scientific Center for Prevention and Health Protection of Industrial Workers

Yakupov E.Z.

Scientific Research Medical Complex «Your Health»;
Kazan State Medical University

Cyclobenzaprine: new option for pharmacological therapy of back pain. Expert panel opinion

Authors:

Yakhno N.N., Amelin A.V., Akhmadeeva L.R., Barantsevich E.R., Bykov Yu.N., Vorobeva O.V., Volkova L.I., Davydov O.S., Danilov A.B., Devlikamova F.I., Doronina O.V., Iskra D.A., Kamchatnov P.R., Karakulova Yu.V., Kukushkin M.L., Kurushina O.V., Parfenov V.A., Poverennova I.E., Rachin A.P., Churyukanov M.V., Shirokov V.A., Yakupov E.Z.

More about the authors

Journal: Russian Journal of Pain. 2023;21(1): 88‑94

DOI: 10.17116/pain20232101188

Views: 5726

Downloaded: 181

Download PDF (RU)
Contact the author
Table of contents

CYCLOBENZAPRINE: NEW OPTION FOR PHARMACOLOGICAL THERAPY OF BACK PAIN. EXPERT PANEL OPINION
CYCLOBENZAPRINE: NEW OPTION FOR PHARMACOLOGICAL THERAPY OF BACK PAIN. EXPERT PANEL OPINION

To cite this article:

Yakhno NN, Amelin AV, Akhmadeeva LR, et al. . Cyclobenzaprine: new option for pharmacological therapy of back pain. Expert panel opinion. Russian Journal of Pain. 2023;21(1):88‑94. (In Russ.)
https://doi.org/10.17116/pain20232101188

 
Подписка 2025-2 (Russian Journal of Pain)
МСФ на ЯМ
Close metadata

Cyclobenzaprine: new option for pharmacological therapy of back pain. Expert panel opinion.

Authors:

Yakhno N.N.

Sechenov First Moscow State Medical University

Amelin A.V.

Pavlov First Saint Petersburg State Medical University

Akhmadeeva L.R.

Bashkir State Medical University

Barantsevich E.R.

Pavlov First Saint Petersburg State Medical University

Bykov Yu.N.

Federal State Budget Educational Institution of Higher Training Irkutsk State medical university of the Ministry of Health of the Russian Federation

Vorobeva O.V.

Chuvash state university named after I.N. Ulyanov

Volkova L.I.

Federal State Budget Educational Institution of Higher Education “Ural State Medical University” of the Ministry of Health of the Russian Federation

Davydov O.S.

Research Institute of General Pathology and Pathophysiology

Danilov A.B.

Sechenov First Moscow State Medical University (Sechenov University)

Devlikamova F.I.

Kazan State Medical Academy

Doronina O.V.

Federal State Budget Educational Institution of Higher Training Novosibirsk State medical university of the Ministry of Health of the Russian Federation

Iskra D.A.

Saint Petersburg State Pediatric Medical University

Kamchatnov P.R.

Federal State Autonomous Educational Institution of Higher Education «N.I. Pirogov Russian National Research Medical University» of the Ministry of Health of the Russian Federation

Karakulova Yu.V.

Wagner Perm State Medical University

Kukushkin M.L.

Research Institute of General Pathology and Pathophysiology

Kurushina O.V.

Volgograd State Medical University

Parfenov V.A.

Sechenov First Moscow State Medical University

Poverennova I.E.

Federal State Budgetary Educational Institution of Higher Education «Samara State Medical University» of the Ministry of Healthcare of the Russian Federation

Rachin A.P.

National Research Medical Center for Rehabilitation and Balneology

Churyukanov M.V.

Sechenov First Moscow State Medical University (Sechenov University);
Petrovsky National Research Centre of Surgery

Shirokov V.A.

Yekaterinburg Medical Scientific Center for Prevention and Health Protection of Industrial Workers

Yakupov E.Z.

Scientific Research Medical Complex «Your Health»;
Kazan State Medical University

Received:

10.01.2023

Accepted:

15.01.2023

List of references:

  1. Parfenov V.A., Yakhno N.N., Kukushkin M.L., Churyukanov M.V., Davydov O.S., Golovacheva V.A., Isaikin A.I., Achkasov E.E., Evzikov G.Yu., Karateev A.E., Khabirov F.A., Shirokov V.A. Acute nonspecific (musculoskeletal) low back pain Guidelines of the Russian Society for the Study of Pain (RSSP). Neurology, Neuropsychiatry, Psychosomatics. 2018;10(2):4-11  https://doi.org/10.14412/2074-2711-2018-2-4-11
  2. https://doi.org/10.14412/2074-2711-2019-2S-7-16  Parfenov V.A., Yakhno N.N., Davydov O.S., Kukushkin M.L., Churyukanov M.V., Golovacheva V.A., Isaikin A.I., Achkasov E.E., Evzikov G.Yu., Karateev A.E., Khabirov F.A., Shirokov V.A., Yakupov E.Z. Chronic nonspecific (musculoskeletal) low back pain. Guidelines of the Russian Society for the Study of Pain (RSSP). Neurology, Neuropsychiatry, Psychosomatics. 2019;11(2S):7-16.
  3. WHO factsheet Musculoskeletal health 14.07.2022. https://www.who.int/news-room/fact-sheets/detail/musculoskeletal-conditions
  4. Hartvigsen J, Hancock MJ, Kongsted A, Louw Q, Ferreira ML, Genevay S, Hoy D, Karppinen J, Pransky G, Sieper J, Smeets RJ, Underwood M; Lancet Low Back Pain Series Working Group. What low back pain is and why we need to pay attention. Lancet. 2018;391(10137):2356-2367. Epub 2018 Mar 21. PMID: 29573870. https://doi.org/10.1016/S0140-6736(18)30480-X
  5. Meucci RD, Fassa AG, Muller N, Faria X. Prevalence of chronic low back pain: systematic review. Rev Saúde Pública. 2015;49(73):1-10.  https://doi.org/10.1590/S0034-8910.2015049005874
  6. Shmagel A, Foley R, Ibrahim H. Epidemiology of chronic low back pain in US adults: National Health and Nutrition Examination Survey 2009—2010. Anna Arthritis Care Res. 2017;68(11):1688-1694. https://doi.org/10.1002/acr.22890
  7. https://rosstat.gov.ru/storage/mediabank/Zdravoohran-2021.pdf  https://rosstat.gov.ru/storage/mediabank/Zdravoohran-2021.pdf.
  8. Erdes Sh.F. Non-specific low-back pain. Clinical recommendations for district physicians and general practitioners. Moscow, 2008, 70 p. 
  9. Karateev A.E. Bolezni kostno-myshechnoy sistemy v praktike 2102 vrachey raznykh spetsial’nostey: struktura patologii i mnenie spetsialistov ob effektivnosti NPVP (predvaritel’nye dannye epidemiologicheskogo issledovaniya KORONA-2)//Consilium Medicum.-2013.-Vol. 15.-N.9.-P.95-100. 
  10. ll-Russian non-profit organization “Association of general practitioners of Russian Federation” Chronic back pain Clinical guideline 2014 
  11. Nasonov E.L., Yakhno N.N., Karateev A.E., Alekseeva L.I., Barinov A.N., Barulin A.E., Davydov O.S., Danilov A.B., Zhuravleva M.V., Zavodovsky B.V., Kopenkin S.S., Kukishkin M.L., Parfenov V.A., Strakhov M.A., Tyurin V.P., Chichasova N.V., Chorbinskaya S.A. General principles of treatment for musculoskeletal pain: interdisciplinary consensus. Rheumatology Science and Practice. 2016;54(3):247-265. (In Russ.)
  12. Arendt-Nielsen L, Morlion B, Perrot S, Dahan A, Dickenson A, Kress HG, Wells C, Bouhassira D, Mohr Drewes A. Assessment and manifestation of central sensitisation across different chronic pain conditions. Eur J Pain. 2018;22(2):216-241.  https://doi.org/10.1002/ejp.1140
  13. Chen G, Zhang YQ, Qadri YJ, Serhan CN, Ji RR. Microglia in pain: detrimental and protective roles in pathogenesis and resolution of pain. Neuron. 2018;100(6):1292-1311. https://doi.org/10.1016/j.neuron.2018.11.009
  14. Podchufarova E.V., Yakhno N.N. Back pain. Moscow 2010 368 p. 
  15. Parfenov V.A. Isaykin A.I. Pain in lumbar area Moscow, 2018 200 p. 
  16. Urits I, Burshtein A, Sharma M, et al. Low Back Pain, a Comprehensive Review: Pathophysiology, Diagnosis, and Treatment. Current Pain and Headache Reports. 2019;23:23. 
  17. linical guidelines “Diagnostics and treatment of skeleton-muscular (non-specific” low back pain” Russian interregional society for pain study 2021  https://painrussia.ru/publications/reference-materials-and-guides/%D0%91%D0%A1_%D0%A0%D0%9E%D0%98%D0%91_2020.pdf
  18. Qaseem A, Wilt TJ, McLean RM, Forciea MA; Clinical Guidelines Committee of the American College of Physicians, Denberg TD, Barry MJ, Boyd C, Chow RD, Fitterman N, Harris RP, Humphrey LL, Vijan S. Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline from the American College of Physicians. Ann Intern Med. 2017;166(7):514-530. Epub 2017 Feb 14. PMID: 28192789. https://doi.org/10.7326/M16-2367
  19. van Tulder M, Becker A, Bekkering T, Breen A, del Real MT, Hutchinson A, Koes B, Laerum E, Malmivaara A; COST B13 Working Group on Guidelines for the Management of Acute Low Back Pain in Primary Care. Chapter 3. European guidelines for the management of acute nonspecific low back pain in primary care. Eur Spine J. 2006;15(suppl 2):169-191. PMID: 16550447; PMCID: PMC3454540. https://doi.org/10.1007/s00586-006-1071-2
  20. Instruction for medical use of medicinal product Baclosan P N014785/01 of 06.11.2009 
  21. Instruction for medical use of medicinal product Sirdalud P N012947/01 of 03.08.2010 
  22. Instruction for medical use of medicinal product Midocalm P N002409/01 of 09.10.2008 
  23. Summary of product characteristics of medicinal product Reloprim, marketing authorization LP-№(000677)-(EG-RU) of 11.04.2022 
  24. Label FLEXERIL (CYCLOBENZAPRINE HCL) TABLETS. https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/017821s051lbl.pdf
  25. De Lee JC, Rockwood CA. Skeletal muscle spasm and a review of muscle relaxants. Current Therapeutic Research. 1980;27(1):64-74. 
  26. Kobayashi H, Hasegawa Y, Ono H. Cyclobenzaprine, a centrally acting muscle relaxant, acts on descending serotonergic systems. European Journal of Pharmacology. 1996;311(1):29-35.  https://doi.org/10.1016/0014-2999(96)00402-5
  27. Harvey PJ, Li X, Li Y, Bennett DJ. 5-HT2 receptor activation facilitates a persistent sodium current and repetitive firing in spinal motoneurons of rats with and without chronic spinal cord injury. J Neurophysiol. 2006;96(3):1158-1170. Epub 2006 May 17. PMID: 16707714; PMCID: PMC5726401. https://doi.org/10.1152/jn.01088.2005
  28. Fauss GNK, Hudson KE, Grau JW. Role of Descending Serotonergic Fibers in the Development of Pathophysiology after Spinal Cord Injury (SCI): Contribution to Chronic Pain, Spasticity, and Autonomic Dysreflexia. Biology (Basel). 2022;11(2):234. PMID: 35205100; PMCID: PMC8869318. https://doi.org/10.3390/biology11020234
  29. Murray KC, Stephens MJ, Ballou EW, Heckman CJ, Bennett DJ. Motoneuron excitability and muscle spasms are regulated by 5-HT2B and 5-HT2C receptor activity. J Neurophysiol. 2011;105(2):731-748. Epub 2010 Oct 27. PMID: 20980537; PMCID: PMC3059173. https://doi.org/10.1152/jn.00774.2010
  30. Perrier JF. Modulation of motoneuron activity by serotonin. Dan Med J. 2016;63(2):B5204. PMID: 26836802.
  31. Kalinina NA, Zaitsev AV, Vesselkin NP. Different Effects of 5-HT1 and 5-HT2 Receptor Agonists on Excitability Modulation of Motoneurons in Frog Spinal Cord. J Evol Biochem Phys. 2019;55:284-292.  https://doi.org/10.1134/S0022093019040045
  32. Mestres J, Seifert SA, Oprea TI. Linking pharmacology to clinical reports: cyclobenzaprine and its possible association with serotonin syndrome. Clin Pharmacol Ther. 2011;90(5):662-665. Epub 2011 Oct 5. PMID: 21975349; PMCID: PMC3809033. https://doi.org/10.1038/clpt.2011.177
  33. Cimolai N. Cyclobenzaprine: a new look at an old pharmacological agent. Expert Review of Clinical Pharmacology. 2009;2(3):255-263.  https://doi.org/10.1586/ecp.09.5
  34. Gorea E, Davenne D, Lanfumey L, Chastanet M, Joëlle A. Regulation of noradrenergic coerulean neuronal firing mediated by 5-HT2 receptors: Involvement of the prepositus hypoglossal nucleus. Neuropharmacology. 1991;30:12:Part A:1309-1318.
  35. Haddjeri N, et al. Modulation of the ®ring activity of noradrenergic neurones in the rat locus coeruleus by the 5-hydroxtryptamine system. British Journal of Pharmacology. 1997;120:865-875. 
  36. Giovannitti JA Jr, Thoms SM, Crawford JJ. Alpha-2 adrenergic receptor agonists: a review of current clinical applications. Anesth Prog. 2015;62(1):31-39. PMID: 25849473; PMCID: PMC4389556. https://doi.org/10.2344/0003-3006-62.1.31
  37. Bonnet F. Mécanisme de l’effet analgésique des agonistes alpha 2 adrénergiques [Mechanisms of the analgesic effect of alpha 2 adrenergic agonists]. Cah Anesthesiol. 1994;42(6):723-725. French. PMID: 7767720.
  38. Kuznetsova LV, Karpova MN, Klishina NYu, Kukushkin ML. Effect of cyclobenzaprine on acute pain in Wistar male rats. Russian Journal of Pain. 2022;20(2):11-15. (In Russ.). https://doi.org/10.17116/pain20222002111
  39. Kuznetsova LV, Karpova MN, Klishina NYu, Kukushkin ML. Effect of cyclobenzaprine on the dynamics of neuropathic pain syndrome development in Wistar male rats. Russian Journal of Pain. 2022;20(3):5-9. (In Russ.). https://doi.org/10.17116/pain2022200315
  40. Van Toulder MW, Touray T, Furlan AD, Solway S, Bouter LM. Muscle relaxants for non-specific low-back pain (Review). Cochrane Database of Systematic Reviews. 2003;4:CD004252.
  41. Browning R, Jackson JL, O’Malley PG. Cyclobenzaprine and Back Pain: A Meta-analysis. Arch Intern Med. 2001;161(13):1613-1620. https://doi.org/10.1001/archinte.161.13.1613
  42. Clinical Study Report RND071700 Blinded placebo-controlled multicenter randomized efficacy safety tolerability and pharmacokinetic study of Cyclobenzaprin, film-coated tablets 10 mg (JSC AKRIKHIN, Russia) in patients with pathologically increased tonus and spasm of skeletal muscles in non-specific cervical and low back pain 13.04.202 
  43. Bennett RM, Gatter RA, Campbell SM, Andrews RP, Clark SR, Scarola JA. A comparison of cyclobenzaprine and placebo in the management of fibrositis. A double-blind controlled study. Arthritis Rheum. 1988;31(12):1535-1542. PMID: 3058130. https://doi.org/10.1002/art.1780311210
  44. Sullivan G, Kelley M, Iserson A, Peters P, Peters A, Flint C, Gendreau J, Harris H, Vaughn B, Lederman S. Efficacy and Safety of TNX-102 SL (Sublingual Cyclobenzaprine) for the Treatment of Fibromyalgia in the RELIEF Study: Positive Results of a Phase 3 Randomized, Double-Blind, Placebo-Controlled Multicenter Trial Presented at the American Society of Clinical Psychopharmacology (ASCP) 2021 Annual Meeting Virtual Conference, June 01-04, 2021; Virtual Poster Session I, Wednesday, June 2, 11:00AM-Noon EDT. 
  45. Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, Häuser W, Fluß E, Choy E, Kosek E, Amris K, Branco J, Dincer F, Leino-Arjas P, Longley K, Mc-Carthy GM, Makri S, Perrot S, Sarzi-Puttini P, Taylor A, Jones GT. EU-LAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017;76(2):318-328. Epub 2016 July 4. PMID: 27377815. https://doi.org/10.1136/annrheumdis-2016-209724

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.